AI Article Synopsis

  • Polycystic ovary syndrome (PCOS) affects 5-15% of premenopausal women and is characterized by hormonal imbalances and ovarian abnormalities, with only a small part of its genetic basis understood so far.* -
  • This study aimed to explore the role of rare genetic variants in the development of PCOS by analyzing DNA from 261 individuals across 62 families with affected daughters.* -
  • The research identified significant associations between rare genetic variants in the DENND1A gene and reproductive/metabolic traits, supporting the idea that DENND1A is crucial to PCOS and suggesting that these rare variants influence the disease’s development.*

Article Abstract

Context: Polycystic ovary syndrome (PCOS) is among the most common endocrine disorders of premenopausal women, affecting 5% to15% of this population depending on the diagnostic criteria applied. It is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. PCOS is highly heritable, but only a small proportion of this heritability can be accounted for by the common genetic susceptibility variants identified to date.

Objective: The objective of this study was to test whether rare genetic variants contribute to PCOS pathogenesis.

Design, Patients, And Methods: We performed whole-genome sequencing on DNA from 261 individuals from 62 families with one or more daughters with PCOS. We tested for associations of rare variants with PCOS and its concomitant hormonal traits using a quantitative trait meta-analysis.

Results: We found rare variants in DENND1A (P = 5.31 × 10-5, adjusted P = 0.039) that were significantly associated with reproductive and metabolic traits in PCOS families.

Conclusions: Common variants in DENND1A have previously been associated with PCOS diagnosis in genome-wide association studies. Subsequent studies indicated that DENND1A is an important regulator of human ovarian androgen biosynthesis. Our findings provide additional evidence that DENND1A plays a central role in PCOS and suggest that rare noncoding variants contribute to disease pathogenesis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660913PMC
http://dx.doi.org/10.1210/jc.2018-02496DOI Listing

Publication Analysis

Top Keywords

variants dennd1a
12
quantitative trait
8
rare noncoding
8
noncoding variants
8
polycystic ovary
8
ovary syndrome
8
pcos
8
variants contribute
8
rare variants
8
variants
7

Similar Publications

The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015.

Endocr Rev

July 2024

Department of Pediatrics and Medicine, The University of Chicago, Chicago, IL 94109, USA.

From 1965 to 2015, immense strides were made into understanding the mechanisms underlying the common androgen excess disorders, premature adrenarche and polycystic ovary syndrome (PCOS). The author reviews the critical discoveries of this era from his perspective investigating these disorders, commencing with his early discoveries of the unique pattern of plasma androgens in premature adrenarche and the elevation of an index of the plasma free testosterone concentration in most hirsute women. The molecular genetic basis, though not the developmental biologic basis, for adrenarche is now known and 11-oxytestosterones shown to be major bioactive adrenal androgens.

View Article and Find Full Text PDF

A neurodevelopmental disorder associated with a loss-of-function missense mutation in RAB35.

J Biol Chem

April 2024

Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. Electronic address:

Rab35 (Ras-associated binding protein) is a small GTPase that regulates endosomal membrane trafficking and functions in cell polarity, cytokinesis, and growth factor signaling. Altered Rab35 function contributes to progression of glioblastoma, defects in primary cilia formation, and altered cytokinesis. Here, we report a pediatric patient with global developmental delay, hydrocephalus, a Dandy-Walker malformation, axial hypotonia with peripheral hypertonia, visual problems, and conductive hearing impairment.

View Article and Find Full Text PDF

Background: Polycystic ovary syndrome (PCOS) is a complex multifactorial disorder with a substantial genetic component. However, the clinical manifestations of PCOS are heterogeneous with notable differences between lean and obese women, implying a different pathophysiology manifesting in differential body mass index (BMI). We performed a meta-analysis of genome-wide association study (GWAS) data from six well-characterised cohorts, using a case-control study design stratified by BMI, aiming to identify genetic variants associated with lean and overweight/obese PCOS subtypes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates whether polycystic ovary syndrome (PCOS) was subject to evolutionary selection in ancient times and why its prevalence remains high despite its fertility impairments.
  • Results suggest that positive selection has likely occurred for certain genetic variants associated with PCOS, indicating a possible explanation for its widespread occurrence today.
  • The analysis focused on 37 specific genetic markers (SNPs) related to PCOS in over 2,500 individuals, revealing significant evidence of positive selection particularly in genes like DENND1A and THADA, which are well-known for their connection to the disorder.
View Article and Find Full Text PDF

Polycystic Ovary Syndrome (PCOS) is a complex genetic disorder in reproductive-aged women which is associated with comorbidities of reproductive, metabolic, cardiovascular, endocrine, and psychological nature. PCOS is the most common cause of anovulatory infertility. Pathogenesis of PCOS involves strong interaction between environmental and genetic factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!